The etiology of RDD remains unclear, but our molecular results provide an implication that MAPK/ERK pathway may play an important role in the pathogenesis of cutaneous RDD, especially NRAS mutation. The gene discussed is MAPK1; the disease is sinus histiocytosis with massive lymphadenopathy.